Neogen Chemicals Limited (NEOGEN) - Net Assets
Based on the latest financial reports, Neogen Chemicals Limited (NEOGEN) has net assets worth Rs8.16 Billion INR (≈ $88.27 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs29.02 Billion ≈ $313.83 Million USD) and total liabilities (Rs20.86 Billion ≈ $225.55 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check NEOGEN intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs8.16 Billion |
| % of Total Assets | 28.13% |
| Annual Growth Rate | 36.45% |
| 5-Year Change | 85.83% |
| 10-Year Change | 1832.96% |
| Growth Volatility | 43.51 |
Neogen Chemicals Limited - Net Assets Trend (2014–2026)
This chart illustrates how Neogen Chemicals Limited's net assets have evolved over time, based on quarterly financial data. See NEOGEN defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Neogen Chemicals Limited (2014–2026)
The table below shows the annual net assets of Neogen Chemicals Limited from 2014 to 2026. For live valuation and market cap data, see NEOGEN company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | Rs8.16 Billion ≈ $88.27 Million |
+3.40% |
| 2025-03-31 | Rs7.89 Billion ≈ $85.37 Million |
+3.83% |
| 2024-03-31 | Rs7.60 Billion ≈ $82.22 Million |
+57.57% |
| 2023-03-31 | Rs4.83 Billion ≈ $52.18 Million |
+9.85% |
| 2022-03-31 | Rs4.39 Billion ≈ $47.50 Million |
+139.99% |
| 2021-03-31 | Rs1.83 Billion ≈ $19.79 Million |
+17.14% |
| 2020-03-31 | Rs1.56 Billion ≈ $16.90 Million |
+122.57% |
| 2019-03-31 | Rs702.01 Million ≈ $7.59 Million |
+40.23% |
| 2018-03-31 | Rs500.62 Million ≈ $5.41 Million |
+18.55% |
| 2017-03-31 | Rs422.28 Million ≈ $4.57 Million |
+53.28% |
| 2016-03-31 | Rs275.49 Million ≈ $2.98 Million |
+17.29% |
| 2015-03-31 | Rs234.87 Million ≈ $2.54 Million |
+19.87% |
| 2014-03-31 | Rs195.93 Million ≈ $2.12 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Neogen Chemicals Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Rs263.80 Million | 3.23% |
| Other Components | Rs7.90 Billion | 96.77% |
| Total Equity | Rs8.16 Billion | 100.00% |
Neogen Chemicals Limited Competitors by Market Cap
The table below lists competitors of Neogen Chemicals Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Australian Agricultural Company Ltd
AU:AAC
|
$571.50 Million |
|
Vibhavadi Medical Center Public Company Limited
BK:VIBHA
|
$571.62 Million |
|
Sincere Navigation Corp
TW:2605
|
$571.70 Million |
|
DBAPPSecurity Co Ltd
SHG:688023
|
$571.74 Million |
|
Hubei Biocause Heilen Pharmaceutical Co. Ltd.
SHE:301211
|
$571.36 Million |
|
Everspin Technologies Inc
NASDAQ:MRAM
|
$571.18 Million |
|
Jamna Auto Industries Limited
NSE:JAMNAAUTO
|
$571.18 Million |
|
GENERAL Elevator Co. Ltd.
SHE:300931
|
$571.04 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Neogen Chemicals Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 7,893,900,000 to 8,162,500,000, a change of 268,600,000 (3.4%).
- Net income of 287,500,000 contributed positively to equity growth.
- Dividend payments of 26,400,000 reduced retained earnings.
- Share repurchases of 7,900,000 reduced equity.
- Other comprehensive income decreased equity by 133,400,000.
- Other factors increased equity by 148,800,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs287.50 Million | +3.52% |
| Dividends Paid | Rs26.40 Million | -0.32% |
| Share Repurchases | Rs7.90 Million | -0.1% |
| Other Comprehensive Income | Rs-133.40 Million | -1.63% |
| Other Changes | Rs148.80 Million | +1.82% |
| Total Change | Rs- | 3.40% |
Book Value vs Market Value Analysis
This analysis compares Neogen Chemicals Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.23x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 197.73x to 6.23x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-03-31 | Rs9.76 | Rs1929.50 | x |
| 2015-03-31 | Rs11.70 | Rs1929.50 | x |
| 2016-03-31 | Rs13.72 | Rs1929.50 | x |
| 2017-03-31 | Rs21.03 | Rs1929.50 | x |
| 2018-03-31 | Rs25.03 | Rs1929.50 | x |
| 2019-03-31 | Rs34.96 | Rs1929.50 | x |
| 2020-03-31 | Rs66.96 | Rs1929.50 | x |
| 2021-03-31 | Rs78.43 | Rs1929.50 | x |
| 2022-03-31 | Rs176.12 | Rs1929.50 | x |
| 2023-03-31 | Rs193.48 | Rs1929.50 | x |
| 2024-03-31 | Rs297.72 | Rs1929.50 | x |
| 2025-03-31 | Rs299.17 | Rs1929.50 | x |
| 2026-03-31 | Rs309.47 | Rs1929.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Neogen Chemicals Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.52%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.34%
- • Asset Turnover: 0.30x
- • Equity Multiplier: 3.56x
- Recent ROE (3.52%) is below the historical average (15.13%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 18.59% | 4.94% | 1.17x | 3.21x | Rs16.84 Million |
| 2015 | 21.65% | 6.06% | 1.22x | 2.93x | Rs27.36 Million |
| 2016 | 18.80% | 5.16% | 1.25x | 2.92x | Rs24.25 Million |
| 2017 | 18.19% | 6.98% | 0.72x | 3.61x | Rs34.60 Million |
| 2018 | 20.97% | 6.51% | 0.90x | 3.60x | Rs54.91 Million |
| 2019 | 29.84% | 8.76% | 0.97x | 3.51x | Rs139.27 Million |
| 2020 | 18.34% | 9.36% | 0.86x | 2.27x | Rs130.32 Million |
| 2021 | 17.12% | 9.31% | 0.68x | 2.69x | Rs130.28 Million |
| 2022 | 10.16% | 9.16% | 0.61x | 1.82x | Rs7.06 Million |
| 2023 | 10.36% | 7.28% | 0.65x | 2.18x | Rs17.18 Million |
| 2024 | 4.69% | 5.16% | 0.47x | 1.92x | Rs-403.79 Million |
| 2025 | 4.41% | 4.48% | 0.45x | 2.21x | Rs-441.09 Million |
| 2026 | 3.52% | 3.34% | 0.30x | 3.56x | Rs-528.75 Million |
Industry Comparison
This section compares Neogen Chemicals Limited's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $4,415,309,840
- Average return on equity (ROE) among peers: 15.06%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Neogen Chemicals Limited (NEOGEN) | Rs8.16 Billion | 18.59% | 2.56x | $571.37 Million |
| Aarti Industries Limited (AARTIIND) | $3.75 Billion | 25.25% | 1.91x | $1.91 Billion |
| Aarti Surfactants Limited (AARTISURF) | $1.36 Billion | 4.04% | 1.96x | $35.50 Million |
| ABM International Limited (ABMINTLLTD) | $148.54 Million | -22.96% | 1.64x | $4.23 Million |
| Advanced Enzyme Technologies Limited (ADVENZYMES) | $8.67 Billion | 14.91% | 0.13x | $452.18 Million |
| Aether Industries Limited (AETHER) | $3.87 Billion | 28.16% | 0.99x | $1.66 Billion |
| Akzo Nobel India Limited (AKZOINDIA) | $8.48 Billion | 17.72% | 1.40x | $1.60 Billion |
| Alkali Metals Limited (ALKALI) | $293.96 Million | 25.87% | 0.91x | $9.63 Million |
| Alkyl Amines Chemicals Limited (ALKYLAMINE) | $11.69 Billion | 19.56% | 0.36x | $990.72 Million |
| Ami Organics Limited (AMIORG) | $822.19 Million | 28.33% | 1.59x | $1.18 Billion |
| Anupam Rasayan India Limited (ANURAS) | $5.07 Billion | 9.71% | 1.61x | $1.58 Billion |
About Neogen Chemicals Limited
Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds … Read more